Kristen Blume
Family Medicine · Fishers, INNPI 1053631929
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $620 and has fallen 97.8% since, to $14 in 2024.
Across 84 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$176
- Novo Nordisk$116
- AbbVie$111
- Astellas Pharma US Inc$111
- Vanda Pharmaceuticals Inc.$83
- Sanofi-aventis U.S. LLC$80
- plus $556 from 19 others
What the payments were for
- Food & beverage$1,227100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $176 |
| Novo Nordisk | 9 | $116 |
| AbbVie(2 entities) | 6 | $111 |
| Astellas Pharma US Inc | 6 | $111 |
| Vanda Pharmaceuticals Inc. | 5 | $83 |
| Sanofi-aventis U.S. LLC | 6 | $80 |
| Lilly USA, LLC | 4 | $55 |
| Arbor Pharmaceuticals, Inc. | 1 | $53 |
| Merck | 3 | $46 |
| Novartis | 3 | $44 |
| Pfizer | 3 | $42 |
| GSK | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Eisai Inc. | 2 | $29 |
| Tactile Systems Technology Inc | 2 | $29 |
| Ironshore Pharmaceuticals Inc. | 2 | $26 |
| Nalpropion Pharmaceuticals LLC | 1 | $20 |
| Romark Laboratories, LC | 1 | $17 |
| Amgen | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Vertiflex, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$1,233 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Fishers
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.